Abstract
In order to improve the accuracy for quantitating the bovine foamy virus (BFV) in vitro, we developed a baby hamster kidney cell (BHK)-21-derived indicator cell line containing a plasmid that encodes the firefly luciferase driven by the BFV long terminal repeat promoter (LTR, from −7 to 1012). The BFV titer could be determined by detecting the luciferase expression since the viral trans-activator BTas protein activates the promoter activity of the LTR. One clone, designated BFVL, was selected from ten neomycin-resistant clones. BFVL showed a specific and inducible dose- and time-dependent luciferase activity in response to BFV infection. Although the changes in luciferase activity of BFVL peaked at 84 h post infection, it was possible to differentiate infected and uninfected cells at 48 h post infection. A linear relationship was established between the multiplicity of infection (MOI) of BFV and the activated ratio of luciferase expression in BFVL. Moreover, the sensitivity of the BFVL-based assay for detecting infectious BFV was 10,000 times higher than the conventional CPE-based assay at 48 h post infection. These findings suggest that the BFVL-based assay is rapid, easy, sensitive, quantitative and specific for detection of BFV infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Broussard S R, Comuzzie A G, Leighton K L, et al. 1997. Characterization of new simian foamy viruses from African nonhuman primates. Virology, 237: 349–359.
Delelis O, Lehmann-Che J, Saib A. 2004. Foamy viruses—a world apart. Curr Opin Microbiol, 7: 400–406.
Diao L, Zhang B, Fan J, et al. 2005. Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination. Cell Signal, 17: 217–229.
Hatama S, Otake K, Omoto S, et al. 2001. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera. J Gen Virol, 82: 2999–3004.
He F, Blair W S, Fukushima J, et al. 1996. The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein. J Virol, 70: 3902–3908.
Herchenroder O, Renne R, Loncar D, et al. 1994. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology, 201: 187–199.
Hill C L, Bieniasz P D, McClure M O. 1999. Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol, 80(Pt 8): 2003–2009.
Hirata R K, Miller A D, Andrews R G, et al. 1996. Transduction of hematopoietic cells by foamy virus vectors. Blood, 88: 3654–3661.
Hsiung G D, Fong C K Y, Landry M L. 1994. Hsiung’s diagnostic virology: as illustrated by light and electron microscopy. 4th ed. New Haven: Yale University Press.
Kido K, Doerks A, Lochelt M, et al. 2002. Identification and functional characterization of an intragenic DNA binding site for the spumaretroviral trans-activator in the human p57Kip2 gene. J Biol Chem, 277: 12032–12039.
Lecellier C H, Neves M, Giron M L, et al. 2002. Further characterization of equine foamy virus reveals unusual features among the foamy viruses. J Virol, 76: 7220–7227.
Linial M. 2000. Why aren’t foamy viruses pathogenic? Trends Microbiol, 8: 284–289.
Liu S, Chen H, Chen J, et al. 1997. Isolation and identification of a bovine spuma virus isolate 3026. Chinese Journal of Virology, 13: 140–145.
Ma Z, Hao P, Yao X, et al. 2008. Establishment of an indicator cell line to quantify bovine foamy virus infection. J Basic Microbiol, 48: 278–283.
Materniak M, Bicka L, Kuzmak J. 2006. Isolation and partial characterization of bovine foamy virus from Polish cattle. Pol J Vet Sci, 9: 207–211.
Mergia A, Luciw P A. 1991. Replication and regulation of primate foamy viruses. Virology, 184: 475–482.
Miyazawa T, Itagaki S, Tomonaga K, et al. 1995. Establishment of carrier-state infection of a feline renal cell line with feline syncytial virus. J Vet Med Sci, 57: 65–69.
Murray S M, Linial M L. 2006. Foamy virus infection in primates. J Med Primatol, 35:225–235.
Phung H T, Tohya Y, Shimojima M, et al. 2003. Establishment of a GFP-based indicator cell line to quantitate feline foamy virus. J Virol Methods, 109: 125–131.
Russell D W, Miller A D. 1996. Foamy virus vectors. J Virol, 70: 217–222.
Santoro M G, Rossi A, Amici C. 2003. NF-kappaB and virus infection: who controls whom. EMBO J, 22: 2552–2560.
Schweizer M, Fleps U, Jackle A, et al. 1993. Simian foamy virus type 3 (SFV-3) in latently infected Vero cells: reactivation by demethylation of proviral DNA. Virology 192: 663–666.
Tai H Y, Sun K H, Kung S H, et al. 2001. A quantitative assay for measuring human foamy virus using an established indicator cell line. J Virol Methods, 94: 155–162.
Tan J, Qiao W, Wang J, et al. 2008. IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus. J Virol, 82: 4275–4283.
Tobaly-Tapiero J, Bittoun P, Neves M, et al. 2000. Isolation and characterization of an equine foamy virus. J Virol, 74: 4064–4073.
Wang J, Guo H Y, Jia R, et al. 2010. Preparation of BFV Gag Antiserum and Preliminary Study on Cellular Distribution of BFV. Virol Sin, 25: 115–122.
Wang J, Tan J, Guo H, et al. 2010. Bovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription. J Virol, 84: 11888–11897.
Wang J, Tan J, Zhang X, et al. 2010. BFV activates the NF-kappaB pathway through its transactivator (BTas) to enhance viral transcription. Virology, 400: 215–223.
Author information
Authors and Affiliations
Corresponding author
Additional information
Foundation items: National Natural Science Foundation of China (31070135, 81071343).
Rights and permissions
About this article
Cite this article
Guo, Hy., Liang, Zb., Li, Y. et al. A new indicator cell line established to monitor bovine foamy virus infection. Virol. Sin. 26, 315–323 (2011). https://doi.org/10.1007/s12250-011-3204-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-011-3204-y